True Capital Management »

iShares NASDAQ Biotechnology Index shares owned by True Capital Management

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by True Capital Management from 13F filings

Historical chart of True Capital Management investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by True Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by True Capital Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $1.1M 8.4k 129.16
2022-12-31 $1.1M 8.5k 131.29

More positions owned by True Capital Management

Apple (AAPL)
Palantir Technologies Cl A (PLTR)
Vanguard Specialized Funds Div App Etf (VIG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C (GOOG)
Alphabet Cap Stk Cl A (GOOGL)
Coinbase Global Com Cl A (COIN)
Vanguard Index Fds Value Etf (VTV)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Us Targeted Vlu (DFAT)

View all positions for True Capital Management

Top funds holding iShares NASDAQ Biotechnology Index

Morgan Stanley
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
UBS Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Commerce Bank N A
Wells Fargo & Company
Royal Bank of Canada
Calamos Advisors
Jane Street
Citadel Advisors
Leucadia National Corporation
Barclays

View all funds holding iShares NASDAQ Biotechnology Index